Mar 09, 2020

HCI Post-Doctoral Fellow Receives Award from the National Cancer Institute

Aria Vaishnavi, PhD, a post-doctoral fellow at Huntsman Cancer Institute at the University of Utah has received the first annual National Cancer Institute Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers. The “Early K99” grant supports researchers who need only a short period of training and mentorship after their doctoral degrees and before they’re hired into a faculty position.

Mar 03, 2020

HCI Researcher Finds Possible Reason for Lung Cancer Driver

About one-third of lung cancer patients who have never smoked have a small portion of DNA missing in the gene called EGFR. This missing portion is a mutation that drives cancer and causes tumors. In a recent study, Lyska Emerson, MD, looked at the patterns of four non-mutated EGFR genes. She was in search of a “destabilizing DNA sequence.” This sequence could explain why that portion of the DNA—called the exon 19 deletion—goes missing in some people.

Feb 20, 2020

Huntsman Cancer Institute to Host 7th Annual Metastatic Breast Cancer Research Conference

The 7th annual Metastatic Breast Cancer Research Conference will be hosted by Huntsman Cancer Institute at the University of Utah in partnership with Baylor College of Medicine and Theresa’s Research Foundation on September 10 and 11, 2020. Participants from around the world are invited to discuss metastatic breast cancer including ongoing research and new ideas from early career scientists.

Feb 18, 2020

Huntsman Cancer Institute Launches New Cancer Genetics Center

A new research initiative at Huntsman Cancer Institute at the University of Utah builds upon Utah’s history of genetic discovery to inform strategies that help affected families reduce their cancer risk. Called the Center for Cancer Genetics at HCI, its initial work includes two statewide projects designed to advance understanding of genetic predisposition of cancer and other disease.

Feb 11, 2020

Researchers Discover a Key Protein in Endometrial Cancer Growth

The hormone estrogen plays many critical roles in men and women, in both healthy tissues and in cancer. In breast and gynecologic cancers, estrogen sends signals to tumors instructing the cancer cells to grow out of control. . In endometrial cancer, which arises in the lining of the uterus, estrogen is known to play a critical role in tumor development, yet many insights from how it affects breast cancer do not apply to endometrial cancer. New research from HCI Researchers outlines findings scientists hope will advance our understanding of endometrial cancer and lead to more effective treatments.

Feb 07, 2020

New CAR-T Target Yields Promising Results for Multiple Myeloma

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.

Feb 07, 2020

HCI Researcher Receives Award to Study Skin Cancer Prevention Behaviors in Children and Families

Yelena Wu, PhD, has been awarded a multi-year Research Scholar Grant totaling nearly $800,000. This award, given by the American Cancer Society, will expand Dr. Wu’s work to rigorously test new behavioral interventions to promote implementation of skin cancer prevention behaviors among Utah children and their parents.

Jan 31, 2020

Construction Notice – Road Work and Building Construction Impacts at Huntsman Cancer Institute Beginning February 3, 2020

Huntsman Cancer Institute at the University of Utah will begin several projects to support the construction of The Kathryn F. Kirk Center for Comprehensive Cancer Care and Women’s Cancers. These projects will impact roadways and parking access at HCI, including the cancer hospital and research center.